Safety Assessment of Alkyl Phosphates as Used in Cosmetics.


Journal

International journal of toxicology
ISSN: 1092-874X
Titre abrégé: Int J Toxicol
Pays: United States
ID NLM: 9708436

Informations de publication

Date de publication:
Historique:
entrez: 17 9 2019
pubmed: 17 9 2019
medline: 20 3 2020
Statut: ppublish

Résumé

The Expert Panel assessed the safety of 28 alkyl phosphates and concluded that these ingredients are safe in the current practices of use and concentration when formulated to be nonirritating. The ingredients in the alkyl phosphate family share a common phosphate core structure, and vary by the identity of the alkyl chains attached therein. Most of the alkyl phosphates function as surfactants in cosmetic ingredients; however, the triesters function as plasticizers rather than surfactants. The Panel reviewed the available animal and clinical data to determine the safety of these ingredients.

Identifiants

pubmed: 31522649
doi: 10.1177/1091581819856582
doi:

Substances chimiques

Cosmetics 0
Phosphates 0
Surface-Active Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

12S-32S

Auteurs

Monice M Fiume (MM)

Cosmetic Ingredient Review Senior Director, DC, USA.

Wilma F Bergfeld (WF)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Donald V Belsito (DV)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Ronald A Hill (RA)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Curtis D Klaassen (CD)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Daniel C Liebler (DC)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

James G Marks (JG)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Ronald C Shank (RC)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Thomas J Slaga (TJ)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Paul W Snyder (PW)

Cosmetic Ingredient Review Expert Panel Member, DC, USA.

Lillian J Gill (LJ)

Former Director, Cosmetic Ingredient Review, DC, USA.

Bart Heldreth (B)

Cosmetic Ingredient Review Executive Director, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH